In addition, using the Gene Expression-Based Outcome for Breast cancer Online (GOBO) [21] with datasets GSE1456, 3494, 7390, representing a total of 737 breast cancers, no relationship was found between sortilin mRNA abundance and clinicopathological parameters (molecular subtypes, lymph node invasion, ER, PR, HER2). This evidence concerns the gene PGR and breast cancer.